logo

Slide Shows

Share SHARE
Events

Biotech Stocks Facing FDA Decision In August We are well into the third quarter and past the middle of the year and it is time to take stock of regulatory decisions awaiting some biotech stocks in August. Despite the uncertain macroeconomic environment, the markets have run up, with the S&P 500 Index making new highs session after session.

The Top Green Companies on Earth Companies that have traditionally pursued growth above everything else are now going green, for good reason.

2Q Earnings Preview: Netflix – It’s Show Time Again Coming off a disappointing quarter, which triggered about 13 percent slide in shares in a single session post the first quarter earnings release, Netflix (NFLX) is once again preparing to confront the Street with its quarterly numbers. Will it be a hit or a damp squib? Hold your breath till you get the box office numbers on Monday.

Will Omnicom Beat Estimates In Q2? Advertising, marketing and corporate communications services provider Omnicom Group Inc. (OMC) is scheduled to release its second-quarter numbers before the bell on Thursday, July 14. Analysts polled by Thomson Reuters are estimating earnings of $1.33 per share on revenue of $3.91 billion. Analysts' estimate typically exclude certain special items.